Literature DB >> 33535452

Pancreastatin Reduces Alternatively Activated Macrophages, Disrupts the Epithelial Homeostasis and Aggravates Colonic Inflammation. A Descriptive Analysis.

Nour Eissa1,2,3,4, Omar Elgazzar1, Hayam Hussein5, Geoffrey N Hendy6, Charles N Bernstein3,4, Jean-Eric Ghia1,2,3,4.   

Abstract

Ulcerative colitis (UC) is characterized by modifying alternatively activated macrophages (AAM) and epithelial homeostasis. Chromogranin-A (CHGA), released by enterochromaffin cells, is elevated in UC and is implicated in inflammation progression. CHGA can be cleaved into several derived peptides, including pancreastatin (PST), which is involved in proinflammatory mechanisms. Previously, we showed that the deletion of Chga decreased the onset and severity of colitis correlated with an increase in AAM and epithelial cells' functions. Here, we investigated PST activity in colonic biopsies of participants with active UC and investigated PST treatment in dextran sulfate sodium (DSS)-induced colitis using Chga-/- mice, macrophages, and a human colonic epithelial cells line. We found that the colonic protein expression of PST correlated negatively with mRNA expression of AAM markers and tight junction (TJ) proteins and positively with mRNA expression of interleukin (IL)-8, IL18, and collagen in human. In a preclinical setting, intra-rectal administration of PST aggravated DSS-induced colitis by decreasing AAM's functions, enhancing colonic collagen deposition and disrupting epithelial homeostasis in Chga+/+ and Chga-/- mice. This effect was associated with a significant reduction in AAM markers, increased colonic IL-18 release, and decreased TJ proteins' gene expression. In vitro, PST reduced Chga+/+ and Chga-/- AAM polarization and decreased anti-inflammatory mediators' production. Conditioned medium harvested from PST-treated Chga+/+ and Chga-/- AAM reduced Caco-2 cell migration, viability, proliferation, and mRNA levels of TJ proteins and increased oxidative stress-induced apoptosis and proinflammatory cytokines release. In conclusion, PST is a CHGA proinflammatory peptide that enhances the severity of colitis and the inflammatory process via decreasing AAM functions and disrupting epithelial homeostasis.

Entities:  

Keywords:  alternatively activated macrophages; chromogranin-A; gut hormones; intestinal epithelial cells; macrophages; mucosal drug action; pancreastatin; proinflammatory peptides

Year:  2021        PMID: 33535452      PMCID: PMC7912769          DOI: 10.3390/biomedicines9020134

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  51 in total

1.  Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.

Authors:  Roni Nowarski; Ruaidhrí Jackson; Nicola Gagliani; Marcel R de Zoete; Noah W Palm; Will Bailis; Jun Siong Low; Christian C D Harman; Morven Graham; Eran Elinav; Richard A Flavell
Journal:  Cell       Date:  2015-12-03       Impact factor: 41.582

Review 2.  Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation.

Authors:  M Zaeem Cader; Arthur Kaser
Journal:  Gut       Date:  2013-11       Impact factor: 23.059

Review 3.  Intestinal epithelial cells: regulators of barrier function and immune homeostasis.

Authors:  Lance W Peterson; David Artis
Journal:  Nat Rev Immunol       Date:  2014-03       Impact factor: 53.106

4.  A Gene Expression Analysis of M1 and M2 Polarized Macrophages.

Authors:  Nour Eissa; Hayam Hussein; Jean-Eric Ghia
Journal:  Methods Mol Biol       Date:  2020

5.  Chromofungin (CHR: CHGA47-66) is downregulated in persons with active ulcerative colitis and suppresses pro-inflammatory macrophage function through the inhibition of NF-κB signaling.

Authors:  Nour Eissa; Hayam Hussein; Laëtitia Kermarrec; Omar Elgazzar; Marie-Helene Metz-Boutigue; Charles N Bernstein; Jean-Eric Ghia
Journal:  Biochem Pharmacol       Date:  2017-08-19       Impact factor: 5.858

6.  Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance.

Authors:  Gautam K Bandyopadhyay; Minh Lu; Ennio Avolio; Jawed A Siddiqui; Jiaur R Gayen; Joshua Wollam; Christine U Vu; Nai-Wen Chi; Daniel T O'Connor; Sushil K Mahata
Journal:  Diabetes       Date:  2014-07-21       Impact factor: 9.461

7.  Activation of murine macrophages.

Authors:  David M Mosser; Xia Zhang
Journal:  Curr Protoc Immunol       Date:  2008-11

Review 8.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

9.  Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis.

Authors:  John T Pesce; Thirumalai R Ramalingam; Margaret M Mentink-Kane; Mark S Wilson; Karim C El Kasmi; Amber M Smith; Robert W Thompson; Allen W Cheever; Peter J Murray; Thomas A Wynn
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

10.  M2 macrophages activate WNT signaling pathway in epithelial cells: relevance in ulcerative colitis.

Authors:  Jesús Cosín-Roger; Dolores Ortiz-Masiá; Sara Calatayud; Carlos Hernández; Angeles Alvarez; Joaquin Hinojosa; Juan V Esplugues; Maria D Barrachina
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.